FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Manuel Quintana

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Phenomena

Recurrence

Geographic Areas

Spain

Co-author Network

Publications

TOP 3
David Salat; Jorge Pagola; Anna Penalba; Manuel Quintana; José Alvarez-Sabín; Alejandro Bustamante; Mireia Campos-Martorell; Alan Flores; Teresa García-Berrocoso; Dolors Giralt; Carlos Molina; Joan Montaner
Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke.
Alberto del Río-Espínola; Pilar Delgado; Sophie Domingues-Montanari; Patricia Fernández-Álvarez; Israel Fernández-Cadenas; Mari Mar Freijo; Dolors Giralt; Maria Gutiérrez-Agulló; Jordi Jiménez Conde; Joan Martí-Fábregas; Sergi Martínez; Maite Mendióroz; Victor Obach; Manuel Quintana; Adoracion Quiroga; Marc Ribo; Jaume Roquer; Agustin Ruíz; Jean Charles Sánchez; Natacha Turck; Mar Castellanos; Pilar Chacón; Elisa Cuadrado Godia; Joan Montaner
A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
A Sierra-Marcos; M Sueiras; M Toledo; M Centeno; M C Edo; Manuel Quintana; R Rovira; J Salas-Puig; Esteban Santamarina; Jose Alvarez-Sabin
Diagnosis of epileptic syndrome after a new onset seizure and its correlation at long-term follow-up: longitudinal study of 131 patients from the emergency room.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Manuel Quintana (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David Salat; Jorge Pagola; Anna Penalba; Manuel Quintana; José Alvarez-Sabín; Alejandro Bustamante; Mireia Campos-Martorell; Alan Flores; Teresa García-Berrocoso; Dolors Giralt; Carlos Molina; Joan Montaner
Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2013;35(3):220-7.
2012: Alberto del Río-Espínola; Pilar Delgado; Sophie Domingues-Montanari; Patricia Fernández-Álvarez; Israel Fernández-Cadenas; Mari Mar Freijo; Dolors Giralt; Maria Gutiérrez-Agulló; Jordi Jiménez Conde; Joan Martí-Fábregas; Sergi Martínez; Maite Mendióroz; Victor Obach; Manuel Quintana; Adoracion Quiroga; Marc Ribo; Jaume Roquer; Agustin Ruíz; Jean Charles Sánchez; Natacha Turck; Mar Castellanos; Pilar Chacón; Elisa Cuadrado Godia; Joan Montaner
A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
Annals of neurology 2012;72(5):716-29.
2011: A Sierra-Marcos; M Sueiras; M Toledo; M Centeno; M C Edo; Manuel Quintana; R Rovira; J Salas-Puig; Esteban Santamarina; Jose Alvarez-Sabin
Diagnosis of epileptic syndrome after a new onset seizure and its correlation at long-term follow-up: longitudinal study of 131 patients from the emergency room.
Epilepsy research 2011;97(1-2):30-6.
2011: Joan Montaner; Anna Penalba; Manuel Quintana; Marc Ribo; Antoni Rosell; Pilar Chacón; Pilar Delgado; Israel Fernández-Cadenas; M Mendioroz; C Molina; José Alvarez-Sabín
A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department.
Journal of internal medicine 2011;270(2):166-74.
2011: Jorge Pagola; Marc Ribo; José Alvarez-Sabin; Marta Rubiera; Estevo Santamarina; Olga Maisterra; Raquel Delgado-Mederos; Gemma Ortega; Manuel Quintana; Carlos A Molina
Thrombolysis in anterior versus posterior circulation strokes: timing of recanalization, ischemic tolerance, and other differences.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2011;21(2):108-12.
2011: M Mendioroz; Israel Fernández-Cadenas; Antoni Rosell; Pilar Delgado; Sophie Domingues-Montanari; Marc Ribo; Anna Penalba; Manuel Quintana; José Alvarez-Sabín; Joan Montaner
Osteopontin predicts long-term functional outcome among ischemic stroke patients.
Journal of neurology 2011;258(3):486-93.
2011: David Salat; Pilar Delgado; Sara Alonso; Marc Ribo; Esteban Santamarina; Manuel Quintana; José Alvarez-Sabín; Joan Montaner
Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients.
European neurology 2011;65(2):82-7.
2010: Mar Hernandez-Guillamon; Lidia Garcia-Bonilla; Montse Solé; Victoria Sosti; Mireia Parés; Mireia Campos; Arantxa Ortega-Aznar; Carmen Domínguez; Marta Rubiera; Marc Ribo; Manuel Quintana; Carlos A Molina; José Alvarez-Sabín; Anna Rosell; Mercedes Unzeta; Joan Montaner
Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Stroke; a journal of cerebral circulation 2010;41(7):1528-35.
2010: Alberto del Río-Espínola; Israel Fernández-Cadenas; Marta Rubiera; Manuel Quintana; Sophie Domingues-Montanari; Maite Mendióroz; Jessica Fernández-Morales; Dolors Giralt; Carlos A Molina; José Alvarez-Sabín; Joan Montaner
CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke.
Pharmacogenomics 2010;11(6):763-72.
2009: Iñigo Les; Rita García-Martínez; Juan Córdoba; Manuel Quintana; Rafael Esteban; Maria Buti
Current trends in chronic hepatitis B management: results of a questionnaire.
European journal of gastroenterology & hepatology 2009;21(10):1177-83.
2009: Bita Sadigh; Kambiz Shahgaldi; Christer Sylvén; Manuel Quintana; Reidar Winter
Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve.
Coronary artery disease 2009;20(5):354-9.
2009: José Alvarez-Sabín; Anna Penalba; Manuel Quintana; Jerzy Krupinski; Lidia García-Bonilla; Joan Montaner
Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2009;28(4):371-7.
2009: Juan F Arenillas; Andreu Massot; Jose Alvarez-Sabín; Israel Fernandez-Cadenas; Albert del Rio-Espinola; Pilar Chacon; Manuel Quintana; Carlos A Molina; Alex Rovira; Joan Montaner
C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
Cerebrovascular diseases (Basel, Switzerland) 2009;28(1):95-102.
2008: Joan Montaner; Mila Perea-Gainza; Pilar Delgado; Marc Ribo; Pilar Chacón; Anna Rosell; Manuel Quintana; Mauricio E Palacios; Carlos A Molina; José Alvarez-Sabín
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Stroke; a journal of cerebral circulation 2008;39(8):2280-7.
2008: Manuel Toledo; Francesc Pujadas; Elisenda Grivé; Jose Alvarez-Sabin; Manuel Quintana; Alex Rovira
Lack of evidence for arterial ischemia in transient global amnesia.
Stroke; a journal of cerebral circulation 2008;39(2):476-9.
2008: Marc Ribo; Carlos A Molina; Angels Pedragosa; Carme Sanclemente; Esteban Santamarina; Marta Rubiera; Raquel Delgado-Mederos; Olga Maisterra; Manuel Quintana; Jose Alvarez-Sabin
Geographic differences in acute stroke care in Catalunya: impact of a regional interhospital network.
Cerebrovascular diseases (Basel, Switzerland) 2008;26(3):284-8.
2008: Beatriz Alvarez; Marc Ribo; Jordi Maeso; Manuel Quintana; Jose Alvarez-Sabin; Manel Matas
Transcervical carotid stenting with flow reversal is safe in octogenarians: a preliminary safety study.
Journal of vascular surgery 2008;47(1):96-100.
2007: José Alvarez-Sabín; Rafael Huertas; Manuel Quintana; Marta Rubiera; Pilar Delgado; Marc Ribo; Carlos A Molina; Joan Montaner
Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator.
Stroke; a journal of cerebral circulation 2007;38(3):1076-8.
2007: Francisco Purroy García; Carlos Alberto Molina Cateriano; Joan Montaner Villalonga; Pilar Delgado Martínez; Esteban Santmarina Pérez; Manuel Toledo; Manuel Quintana; José Alvarez-Sabín
[Lack of usefulness of ABCD score in the early risk of recurrent stroke in transient ischemic attack patients].
Medicina clínica 2007;128(6):201-3.
2007: Francisco Purroy; Joan Montaner; Carlos A Molina; Pilar Delgado; Juan F Arenillas; P Chacon; Manuel Quintana; Jose Alvarez-Sabin
C-reactive protein predicts further ischemic events in transient ischemic attack patients.
Acta neurologica Scandinavica 2007;115(1):60-6.
2006: Pilar Delgado; Jose Alvarez-Sabin; Esteban Santamarina; Carlos A Molina; Manuel Quintana; Anna Rosell; Joan Montaner
Plasma S100B level after acute spontaneous intracerebral hemorrhage.
Stroke; a journal of cerebral circulation 2006;37(11):2837-9.
2006: Israel Fernández-Cadenas; Carlos A Molina; José Alvarez-Sabín; Marc Ribo; Anna Penalba; Laura Ortega-Torres; Pilar Delgado; Manuel Quintana; Anna Rosell; Joan Montaner
ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke.
Neuroscience letters 2006;398(3):167-71.
2006: Francisco Purroy; Joan Montaner; Pilar Delgado; Juan F Arenillas; Carlos A Molina; Esteban Santamarina; Manuel Quintana; José Alvarez-Sabín
[Usefulness of urgent combined carotid/transcranial ultrasound testing in early prognosis of TIA patients].
Medicina clínica 2006;126(17):647-50.
2005: Manuel Toledo; Francesc Pujadas; Francisco Purroy; Noemí Lara; Manuel Quintana; Jose Alvarez-Sabin
[Recurrent Transient Global Amnesia, a manifestation of ischemic cerebrovascular disease].
Medicina clínica 2005;125(10):361-5.
2005: Marc Ribo; Carlos Molina; Joan Montaner; Marta Rubiera; Raquel Delgado-Mederos; Juan F Arenillas; Manuel Quintana; José Alvarez-Sabín
Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.
Stroke; a journal of cerebral circulation 2005;36(8):1705-9.
2005: Esteban Santamarina; Marta Rubiera; Carlos A Molina; M Teresa González Alujas; Arturo Evangelista; Verónica Muñoz; Alex Rovira; Manuel Quintana; José Alvarez-Sabín
[Functional outcome after one year follow-up in cryptogenetic brain infarction and patent foramen ovale].
Medicina clínica 2005;124(15):561-5.
2005: Marc Ribo; Carlos A Molina; Alex Rovira; Manuel Quintana; Pilar Delgado; Joan Montaner; Elisenda Grivé; Juan F Arenillas; José Alvarez-Sabín
Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
Stroke; a journal of cerebral circulation 2005;36(3):602-6.
2005: Juan F Arenillas; José Alvarez-Sabín; Joan Montaner; Anna Rosell; Carlos A Molina; Alex Rovira; Marc Ribo; Esther Sánchez; Manuel Quintana
Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence.
Stroke; a journal of cerebral circulation 2005;36(1):92-7.
2004: Francisco Purroy; Joan Montaner; Alex Rovira; Pilar Delgado; Manuel Quintana; José Alvarez-Sabín
Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions.
Stroke; a journal of cerebral circulation 2004;35(10):2313-9.
2004: Marc Ribo; Joan Montaner; Carlos A Molina; Juan F Arenillas; Esteban Santamarina; Manuel Quintana; José Alvarez-Sabín
Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
Stroke; a journal of cerebral circulation 2004;35(9):2123-7.
2004: Juan F Arenillas; Carlos A Molina; Pilar Chacón; Alex Rovira; Joan Montaner; Pilar Coscojuela; E Sánchez; Manuel Quintana; José Alvarez-Sabín
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis.
Neurology 2004;63(1):27-32.
2004: José Alvarez-Sabín; Pilar Delgado; Sonia Abilleira; Carlos A Molina; Juan F Arenillas; Marc Ribo; Esteban Santamarina; Manuel Quintana; Jasone Monasterio; Joan Montaner
Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
Stroke; a journal of cerebral circulation 2004;35(6):1316-22.
2004: José Alvarez-Sabín; Carlos Molina; Joan Montaner; Juan F Arenillas; Francesc Pujadas; Rafael Huertas; Jorge Mouriño; Marc Ribo; Esteban Santamarina; Manuel Quintana
[Clinical benefit following the implementation of a specialized urgent stroke care system].
Medicina clínica 2004;122(14):528-31.
2004: Francisco Purroy García; Joan Montaner; Pilar Delgado; Marc Ribo; JF Arenillas-Lara; Manuel Quintana; José Alvarez-Sabín
[Clinical factors predicting the appearance of vascular events following a transient ischemic attack].
Revista de neurologia 2004;38(5):416-21.
2003: Joan Montaner; Israel Fernández-Cadenas; Carlos A Molina; Jasone Monasterio; Juan F Arenillas; Marc Ribo; Manuel Quintana; Pilar Chacón; Antoni L Andreu; José Alvarez-Sabín
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Stroke; a journal of cerebral circulation 2003;34(12):2851-5.
2003: Juan F Arenillas; José Alvarez-Sabín; Carlos A Molina; Pilar Chacón; Joan Montaner; Alex Rovira; Bernardo Ibarra; Manuel Quintana
C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease.
Stroke; a journal of cerebral circulation 2003;34(10):2463-8.
2003: José Alvarez-Sabín; Carlos A Molina; Joan Montaner; Juan F Arenillas; Rafael Huertas; Marc Ribo; Agusti Codina; Manuel Quintana
Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Stroke; a journal of cerebral circulation 2003;34(5):1235-41.
2003: Joan Montaner; Carlos A Molina; Jasone Monasterio; Sonia Abilleira; Juan F Arenillas; Marc Ribo; Manuel Quintana; José Alvarez-Sabín
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Circulation 2003;107(4):598-603.
2003: José Alvarez-Sabín; Carlos A Molina; Sonia Abilleira; Joan Montaner; Fernando García Alfranca; Xavier Jiménez Fabrega; Juan F Arenillas; Rafael Huertas; Marc Ribo; Manuel Quintana; Agusti Codina
[Stroke code impact on the efficacy of thrombolytic treatment].
Medicina clínica 2003;120(2):47-51.
2002: José Alvarez-Sabín; Joan Montaner; Ll Padró; Carlos A Molina; R Rovira; Agusti Codina; Manuel Quintana
Gabapentin in late-onset poststroke seizures.
Neurology 2002;59(12):1991-3.
2001: Manuel Quintana; K Lindvall
Determinants of left ventricular systolic function after acute myocardial infarction: the role of residual myocardial ischaemia.
Coronary artery disease 2001;12(5):393-400.
1998: Manuel Quintana; K Lindvall
Contribution of heart rate variability to long-term risk stratification after myocardial infarction.
European heart journal 1998;19(2):352.
1997: Manuel Quintana; K Lindvall; F Brolund; N Storck; LE Lindblad; L Rydén
Markers of risk after acute myocardial infarction. A comparison of clinical variables, ambulatory and exercise electrocardiography, echocardiography, and stress echocardiography.
Coronary artery disease 1997;8(6):327-34.
1997: Manuel Quintana; N Storck; LE Lindblad; K Lindvall; M Ericson
Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study.
European heart journal 1997;18(5):789-97.
1995: Manuel Quintana; K Lindvall; L Rydén; F Brolund
Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction.
The American journal of cardiology 1995;76(16):1115-21.
1995: Manuel Quintana; K Lindvall; F Brolund; S V Eriksson; L Rydén
Prognostic value of exercise stress testing versus ambulatory electrocardiography after acute myocardial infarction: a 3 year follow-up study.
Coronary artery disease 1995;6(11):865-73.
1995: Manuel Quintana; K Lindvall; F Brolund
Assessment and significance of ST-segment changes detected by ambulatory electrocardiography after acute myocardial infarction.
The American journal of cardiology 1995;76(1):6-13.
1995: Manuel Quintana; K Lindvall; P Carlens; S Bevegård; F Brolund
ST-segment depression on ambulatory electrocardiography in the early in-hospital period after acute myocardial infarction predicts early and late mortality: a short-term and a 3-year follow-up study.
Clinical cardiology 1995;18(7):392-400.